Pharming Group NV reports results for the quarter ended September 30 - Earnings Summary

• Pharming Group NV PHAR.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported breakeven earnings per share. The lone analyst forecast for the quarter was for breakeven results per share.

• Revenue rose 30% to $97.30 million from a year ago; analysts expected $93.43 million.

• Pharming Group NV's reported EPS for the quarter was 1 cent​.

• The company reported quarterly net income of $7.5 million.

• Pharming Group NV shares had fallen by 9.1% this quarter and gained 30.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

This summary was machine generated from LSEG data November 6 at 07:00 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)